Safety study of AXS-14 for fibromyalgia
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study continues to monitor the safety of an investigational drug called AXS-14 in people with fibromyalgia who previously participated in another AXS-14 trial. Researchers want to make sure the treatment remains safe over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have completed participation in the previous AXS-14 fibromyalgia study (AXS-14-FM-301)
- You must be able to attend study visits and follow all study procedures
- Your doctor must believe it is medically safe for you to continue in this study
- You must be willing to report any new health concerns or side effects
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called esreboxetine to see if it helps people with fibromyalgia. First, everyone gets the medicine, then some may switch to a placebo to see if the medicine keeps working better than no treatment.
This trial tests whether MDMA (a drug sometimes called 'ecstasy') can help people with fibromyalgia when used alongside therapy sessions. The goal is to see if it reduces pain and improves quality of life.
This trial is testing two medications, pregabalin and crisugabalin, to see how safe and effective they are for people with fibromyalgia who have not yet tried prescription treatments. You may qualify if your pain is moderate to severe and nondrug approaches haven't helped enough.
This study tests if combining physical exercise with a gentle brain stimulation technique can improve pain, sleep, and fatigue in people with fibromyalgia.
This trial tests whether a nerve stimulation technique can help reduce fibromyalgia symptoms. It is open to women with a confirmed diagnosis of fibromyalgia who have had symptoms for at least three months.
This study tests a combination of two medications (pregabalin and toludesvenlafaxine) to see if it is safe and effective for people with fibromyalgia whose pain has not improved with non-drug treatments and who have not yet tried standard medications for this condition.
Hear when a new Fibromyalgia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.